Anti-Mullerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients

dc.contributor.author	Sahmay, Sezai
dc.contributor.author	Guralp, Onur
dc.contributor.author	Aydogan, Begum
dc.contributor.author	Cepni, Ismail
dc.contributor.author	Oral, Engin
dc.contributor.author	Irez, Tulay
dc.date.accessioned	2021-12-21T08:47:08Z
dc.date.available	2021-12-21T08:47:08Z
dc.date.issued	2013
dc.identifier.issn	0951-3590
dc.identifier.issn	1473-0766
dc.identifier.uri	https://doi.org/10.3109/09513590.2013.769519
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2176
dc.description.abstract	Objective: The purpose of this study is to investigate the role of serum anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH) and antral follicle count (AFC) for the prediction of clinical pregnancy rates (CPR) in women with polycystic ovary s
dc.language.iso	English
dc.publisher	Taylor & Francıs Ltd
dc.title	Anti-Mullerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients
dc.type	Article
dc.relation.journal	Gynecologıcal Endocrınology
dc.identifier.issue	5
dc.identifier.startpage	440
dc.identifier.endpage	443
dc.identifier.volume	29
dc.identifier.doi	10.3109/09513590.2013.769519
dc.relation.issue	5
dc.relation.volume	29

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.